{"related:GZBTKcupgR4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.10697","authors":["ME Weinblatt","ME Weinblatt EC Keystone","ME Weinblatt EC Keystone DE Furst…"],"year":2003,"numCitations":2139,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.10697","citationUrl":"http://scholar.google.com/scholar?cites=2198224783170310169&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:GZBTKcupgR4J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2198224783170310169&hl=en&as_sdt=0,5","publication":"Wiley Online Library","p":1,"exp":1596876814212},{"title":"Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.20217","authors":["EC Keystone","EC Keystone AF Kavanaugh","EC Keystone AF Kavanaugh JT Sharp…"],"year":2004,"numCitations":1313,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.20217","citationUrl":"http://scholar.google.com/scholar?cites=3225455462850908790&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dlISfqcewywJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3225455462850908790&hl=en&as_sdt=0,5","publication":"Wiley Online Library"},{"title":"A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","url":"https://www.nejm.org/doi/full/10.1056/nejm199901283400401","authors":["ME Weinblatt","ME Weinblatt JM Kremer","ME Weinblatt JM Kremer AD Bankhurst…"],"year":1999,"numCitations":2504,"pdf":"https://www.nejm.org/doi/full/10.1056/nejm199901283400401","citationUrl":"http://scholar.google.com/scholar?cites=15148383881374693661&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:HXmXauHeOdIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15148383881374693661&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis","url":"https://www.nejm.org/doi/full/10.1056/NEJM200011303432202","authors":["PE Lipsky","PE Lipsky DMFM van der Heijde…"],"year":2000,"numCitations":3681,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJM200011303432202","citationUrl":"http://scholar.google.com/scholar?cites=2493240282763514271&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:n1HQ0dPEmSIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2493240282763514271&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a …","url":"https://www.sciencedirect.com/science/article/pii/S0140673699052460","authors":["R Maini","R Maini EW St Clair","R Maini EW St Clair F Breedveld","R Maini EW St Clair F Breedveld D Furst","R Maini EW St Clair F Breedveld D Furst J Kalden…"],"year":1999,"numCitations":2841,"pdf":"http://www.informedpharmacotherapy.com/Issue1/AttractEBPReview.htm","citationUrl":"http://scholar.google.com/scholar?cites=12147592277250458555&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:u8PKwdDqlKgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12147592277250458555&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed","url":"https://ard.bmj.com/content/63/5/508.short","authors":["LBA Van de Putte","LBA Van de Putte C Atkins","LBA Van de Putte C Atkins M Malaise…"],"year":2004,"numCitations":706,"pdf":"https://ard.bmj.com/content/annrheumdis/63/5/508.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=5721274109365805890&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:QmNjZ30MZk8J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5721274109365805890&hl=en&as_sdt=0,5","publication":"ard.bmj.com"},{"title":"Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial","url":"https://www.acpjournals.org/doi/abs/10.7326/0003-4819-130-6-199903160-00004","authors":["LW Moreland","LW Moreland MH Schiff","LW Moreland MH Schiff SW Baumgartner…"],"year":1999,"numCitations":1816,"citationUrl":"http://scholar.google.com/scholar?cites=14469665356709449200&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:8E1xdfqTzsgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14469665356709449200&hl=en&as_sdt=0,5","publication":"acpjournals.org"},{"title":"Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid …","url":"http://www.jrheum.org/content/30/12/2563.short","authors":["DE Furst","DE Furst MH Schiff","DE Furst MH Schiff RM Fleischmann…"],"year":2003,"numCitations":635,"citationUrl":"http://scholar.google.com/scholar?cites=2098777087597036973&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:rUXzMKRaIB0J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2098777087597036973&hl=en&as_sdt=0,5","publication":"jrheum.org"},{"title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind …","url":"https://www.sciencedirect.com/science/article/pii/S0140673604156407","authors":["L Klareskog","L Klareskog D van der Heijde","L Klareskog D van der Heijde JP de Jager","L Klareskog D van der Heijde JP de Jager A Gough…"],"year":2004,"numCitations":2107,"pdf":"http://acpjc.acponline.org/Content/141/2/issue/ACPJC-2004-141-2-042.htm","citationUrl":"http://scholar.google.com/scholar?cites=3788006772024382059&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:a5JJ5Ra0kTQJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3788006772024382059&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.21519","authors":["FC Breedveld","FC Breedveld MH Weisman…"],"year":2006,"numCitations":2133,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.21519","citationUrl":"http://scholar.google.com/scholar?cites=12894171158113881425&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UQ13IFpM8bIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12894171158113881425&hl=en&as_sdt=0,5","publication":"Wiley Online Library"}]}